DEVELOPMENT OF ANTISENSE DRUG TARGETING PCSK9

被引：0
|
作者：
Harada-Shiba, M. [1 ]
Wada, F. [1 ]
Tachibana, K. [2 ]
Yamamoto, T. [2 ]
Kobayashi, T. [2 ]
机构：
[1] Natl Cerebral & Cardiovasc Ctr Res Inst, Suita, Osaka, Japan
[2] Osaka Univ, Suita, Osaka, Japan
来源：
ATHEROSCLEROSIS | 2018年 / 275卷
关键词：
D O I：
10.1016/j.atherosclerosis.2018.06.897
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
W4:4
引用
收藏
页码：E4 / E5
页数：2
相关论文
共 50 条
  • [41] The role of PCSK9 in NAFLD/NASH and therapeutic implications of PCSK9 inhibition
    Momtazi-Borojeni, Amir Abbas
    Banach, Maciej
    Ruscica, Massimiliano
    Sahebkar, Amirhossein
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (10) : 1199 - 1208
  • [42] EFFECTS OF PCSK9 VARIANTS AND PCSK9 LEVELS ON RISK OF ISCHEMIC STROKE
    Chen, W.
    Pan, Y.
    Wang, Y.
    Li, H.
    Meng, X.
    Wang, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2020, 15 (1_SUPPL) : 629 - 629
  • [43] Macrophage Expression of Pcsk9 Influences Atherosclerosis Development
    Giunzioni, Ilaria
    Tavori, Hagai
    Covarrubias, Roman
    Major, Amy
    Linton, MacRae F.
    Fazio, Sergio
    CIRCULATION, 2013, 128 (22)
  • [44] PCSK9 GENE PARTICIPATES IN THE DEVELOPMENT OF PRIMARY DYSLIPIDEMIAS
    Matias-Perez, D.
    Perez-Santiago, A. D.
    Medina, Sanchez M. A.
    Alpuche Osorno, J. J.
    Garcia-Montalvo, I. A.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2021, 24 (01) : 5 - 13
  • [45] Targeting PCSK9 With Antibodies and Gene Silencing to Reduce LDL Cholesterol
    Newman, Connie B.
    Tobert, Jonathan A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (04): : 784 - 790
  • [46] Monoclonal antibodies targeting PCSK9 and the search for prolonged duration of effect
    Ridker, Paul M.
    EUROPEAN HEART JOURNAL, 2016, 37 (17) : 1370 - 1372
  • [47] Targeting low-density lipoprotein cholesterol with PCSK9 inhibitors
    Scherer, Daniel J.
    Nelson, Adam J.
    Psaltis, Peter J.
    Nicholls, Stephen J.
    INTERNAL MEDICINE JOURNAL, 2017, 47 (08) : 856 - 865
  • [48] Understanding PCSK9 and anti-PCSK9 therapies
    McKenney, James M.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2015, 9 (02) : 170 - 186
  • [49] Microrna-483 Ameliorates Hypercholesterolemia via Pcsk9 Targeting
    Dong, Jianjie
    He, Ming
    Gordts, Philip
    Tsimikas, Sotirios
    Shyy, John Y.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2020, 40
  • [50] Emerging innovative therapeutic approaches targeting PCSK9 to lower lipids
    Shantha, G. P. S.
    Robinson, J. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 99 (01) : 59 - 71
12345